Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
05/2012
05/15/2012US8178111 GM-negative EHV-mutants without heterologous elements
05/15/2012US8178107 Method of treatment of thrombocytopenia or risk thereof using MPL ligand (thrombopoietin), variants, and fragments thereof
05/15/2012US8178082 Methods for up-regulating PAP1 in animals suffering from pancreatic disorders
05/15/2012CA2681922C Zinc finger protein derivatives and methods therefor
05/15/2012CA2529449C Pharmaceutical composition comprising cyclic somatostatin analogues
05/15/2012CA2519174C Improved osteoinductive materials
05/15/2012CA2516581C Attenuated strains of vibrio cholerae with improved biological safety features in freeze dried form for oral vaccination
05/15/2012CA2497496C In vitro peptide expression library
05/15/2012CA2450476C A soluble complex comprising a retroviral surface glycoprotein
05/15/2012CA2440592C Oxidation-reduction sensitive green fluorescent protein variants
05/15/2012CA2439452C High-affinity antagonists of elr-cxc chemokines
05/15/2012CA2434237C Glp-1 fusion proteins
05/15/2012CA2409940C Anti-listeria bacteriocin
05/15/2012CA2368385C Prostate-specific gene, pcgem1, and methods of using pcgem1 to detect, treat, and prevent prostate cancer
05/15/2012CA2348366C Nucleic acid molecules from rice and their use for the production of modified starch
05/15/2012CA2335098C Protease susceptibility ii
05/15/2012CA2288307C Novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells and antibodies that identify the same
05/15/2012CA2169502C Plants having enhanced nitrogen assimilation/metabolism
05/10/2012WO2012061750A2 Peptide compositions that downregulate tlr-4 signaling pathway and methods of producing and using same
05/10/2012WO2012061637A2 Hsv-1 epitopes and methods for using same
05/10/2012WO2012061615A1 Transcription factors for modification of lignin content in plants
05/10/2012WO2012061530A2 Oplophorus-derived luciferases, novel coelenterazine substrates, and methods of use
05/10/2012WO2012061443A2 Compositions of a peptide-based system for cell-specific targeting
05/10/2012WO2012061291A2 Methods and compositions for cell separation of blood tissues
05/10/2012WO2012061281A1 Diagnostic assays and methods of use for detection of filarial infection
05/10/2012WO2012060666A2 Method for producing human epidermal growth factor in large volume from yeast
05/10/2012WO2012060572A2 Cloning and base sequence determination of novel iturin biosynthesis gene from antagonistic microorganism bacillus subtilis and characteristics of the gene
05/10/2012WO2012060120A1 Protein showing specific localization in fat droplets
05/10/2012WO2012060025A1 Production of neutral antibody to human herpes virus 6 glycoprotein q1 and analysis thereof
05/10/2012WO2012059777A1 Lung tissue model
05/10/2012WO2012059593A1 Vaccines for preventing meningococcal infections
05/10/2012WO2012059592A1 Compounds for delivering a therapeutic or imaging agent to the brain
05/10/2012WO2012059559A1 Stress-resistant plants and their production
05/10/2012WO2012059556A1 Novel antigen of enterococcal pathogens and use thereof as vaccine component for therapy and/or prophylaxis
05/10/2012WO2012059486A1 Albumin variants
05/10/2012WO2012059243A2 Modulation of immune responses by the poxviral k4 protein
05/10/2012WO2012059223A1 Methods and vectors for cell immortalisation
05/10/2012WO2012059217A1 Densovirus-derived vector for gene transfer in insects
05/10/2012WO2012059069A1 Polypeptides having cellobiohydrolase activity and polynucleotides encoding same
05/10/2012WO2012059053A1 Polypeptides having cellobiohydrolase activity and polynucleotides encoding same
05/10/2012WO2012058814A1 FCA-γ RRM2 GENE AND ITS USE FOR IMPROVING TRAITS IN INDUSTRIAL CROPS
05/10/2012WO2012058762A1 Plant expression system
05/10/2012WO2012058715A1 Immune-modulating agents and uses therefor
05/10/2012WO2012031103A3 Inhibitors of bcl-2
05/10/2012WO2012024176A3 Novel bacillus thuringiensis gene with lepidopteran activity
05/10/2012WO2012017439A3 Methods of treating autoimmune diseases of the central nervous system (cns) and neurodegenerative diseases
05/10/2012WO2012012667A3 Methods and compositions for modification of a hla locus
05/10/2012WO2012012656A3 Materials and methods for treating neurodegenerative diseases
05/10/2012WO2012012352A3 Modified peptides and proteins
05/10/2012WO2011161420A3 Coincidence detection
05/10/2012WO2011156331A3 Human neural progenitor derived dopaminergic progenitors and neurons
05/10/2012WO2011110953A8 Polyepitope constructs and methods for their preparation and use
05/10/2012WO2011110359A8 Stat3 activation inhibitors
05/10/2012WO2011006717A3 Plants having enhanced yield-related traits and a method for making the same
05/10/2012US20120117690 Novel bacillus thuringiensis crystal polypeptides, polynucleotides, and compositions thereof
05/10/2012US20120116061 Method of arraying ferritin
05/10/2012US20120116055 Novel canola protein isolate
05/10/2012US20120116053 Expression of triple-helical collagen-like products in e.coli
05/10/2012US20120116052 Nucleic Acid Molecules Encoding TNF-Alpha Ligand Polypeptides Having a CD154 Domain
05/10/2012US20120115937 Ghrelin binding nucleic acids
05/10/2012US20120115934 Organic Compositions to Treat Beta-ENaC-Related Diseases
05/10/2012US20120115933 Organic Compositions to Treat Beta-ENaC-Related Diseases
05/10/2012US20120115928 Mirna and its targets respectively the proteins made based on the targets as a prognostic, diagnostic biomarker and therapeutic agent for cancer
05/10/2012US20120115796 Novel Spacer Moiety for Poly(ehtylene Glycol) Modified Peptide Based Compounds
05/10/2012US20120115795 Regulation of Sodium Channels by PLUNC Proteins
05/10/2012US20120115793 Peptidomimetic macrocycles
05/10/2012US20120115789 Methylglyoxal-Scavenging Compounds and Their Use for the Prevention and Treatment of Pain and/or Hyperalgesia
05/10/2012US20120115783 Peptidomimetic macrocycles
05/10/2012US20120115776 Adiponectin-containing eating behavior control agent for oral administration
05/10/2012US20120115775 Mutant tat proteins and uses thereof
05/10/2012US20120115773 Modified omci as a complement inhibitor
05/10/2012US20120115749 Tumour Markers
05/10/2012US20120115746 Compositions and methods for treating and diagnosing irritable bowel syndrome
05/10/2012US20120115244 Materials and methods for immunoassay of pterins
05/10/2012US20120115233 Leafhopper Ecdysone Receptor Nucleic Acids, Polypeptides, and Uses Thereof
05/10/2012US20120115204 Virus filtration of liquid factor vii compositions
05/10/2012US20120115169 Hydroxycholesterol immunoassay
05/10/2012US20120115164 Mammalian cytokines; related reagents
05/10/2012US20120115161 Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth
05/10/2012US20120115153 Marker for prognosis of liver cancer
05/10/2012US20120115136 Pna diagnostic use
05/10/2012US20120114742 Polymer Conjugates with Decreased Antigenicity, Methods of Preparation and Uses Thereof
05/10/2012US20120114708 Integrin heterodimer and an alpha subunit thereof
05/10/2012US20120114703 Botulinum Toxin Administration to Treat Various Conditions
05/10/2012US20120114700 Lat adapter molecule for enhanced t-cell signaling and method of use
05/10/2012US20120114699 Allergoids Derived from Allergens
05/10/2012US20120114698 Salmonella marker vaccine
05/10/2012US20120114694 Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
05/10/2012US20120114686 Compositions and methods related to protein a (spa) variants
05/10/2012US20120114684 Compounds and methods for treatment and diagnosis of chlamydial infection
05/10/2012US20120114683 Nucleic Acid Encoding TGEV and PRRSV Sequences for Improved Expression of PRRSV Sequences
05/10/2012US20120114682 Peptides for binding fibrinogen and fibrin
05/10/2012US20120114679 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
05/10/2012US20120114674 Molecular Antigen Array
05/10/2012US20120114667 TARGETED BINDING AGENTS DIRECTED TO a5BETA1 AND USES THEREOF
05/10/2012US20120114630 Variants of plasminogen and plasmin
05/10/2012US20120114619 Protein with promoting effects for axonal growth of neurons of central nervous system
05/10/2012US20120114603 Ifn-alpha/beta-independent mechanism of antiviral protection through a novel ligand-receptor pair: ifn- ligands engage a novel receptor ifn-rn (crf2-12) and il-10r2 (crf2-4) for signaling andinduction of biological activities
05/10/2012US20120114558 Aptamer-mediated drug release
05/10/2012US20120114557 Methods for Collagen Imaging
1 ... 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 ... 2916